gut.bmj18h
Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
Correspondence to Dr Simon PL Travis, Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK; simon.travis{at}ndm.ox.ac.uk Background Endoscopic mucosal healing is an ...
gut.bmj20h
Defensins and innate host defence of the gastrointestinal tract
Department of Immunology, Gastroenterology and Colorectal Surgery, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA Department of Medicine and The Will Rogers ...
gut.bmj1d
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study
Correspondence to Dr Ka Shing Cheung, Department of Medicine, The University of Hong Kong, Hong Kong 999077, Hong Kong; cks634{at}hku.hk; Prof Wai-Kay Seto; wkseto{at}hku.hk Objective Whether varying ...
gut.bmj1d
PTU-211 Patient preparation prior to gastroscopy: a UK wide survey
Introduction Background: Optimal patient preparation for colonoscopy is shown to improve polyp detection in the colon. In Japan, it is widely accepted practice to administer a mucolytic agent prior to ...
gut.bmj2d
Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs
Dr M J A P Govers, Numico Research BV, PO Box 7005, 6700 CA Wageningen, The Netherlands. BACKGROUND Recent studies suggest that resistant starch (effective in producing butyrate and lowering possibly ...
gut.bmj2d
Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn’s disease
Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...
gut.bmj2d
Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.
BACKGROUND: 6-Mercaptopurine and its prodrug azathioprine are effective medications for refractory inflammatory bowel disease. However, use of these drugs has been limited by concerns about their ...
gut.bmj2d
Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?
Correspondence to Professor Peter Gibson, Department of Gastroenterology, Alfred Hospital, 99 Commercial Road, Melbourne Victoria 3004, Australia; peter.gibson{at}monash.edu IBS is one of the most ...
gut.bmj3d
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
4 Department of Hepatogastroenterology, Hopital Claude Huriez, CHRU Lille, France Correspondence to: Professor J-F Colombel Department of Hepato-Gastroenterology, Hopital Claude Huriez, CHRU de Lille, ...
gut.bmj3d
Functional gastrointestinal disorders: psychological, social, and somatic features
Associate Professor J E Kellow, Department of Medicine, Royal North Shore Hospital, St Leonards, NSW 2065, Australia. Background—Psychological, social, and extraintestinal (somatic) disturbances are ...
gut.bmj3d
Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation
1 Department of Immunology, Pole of Biology, Hôpital Archet 1, CHU de Nice, Université de Nice Sophia-Antipolis, Nice, France 2 EA 6203, Université de Nice Sophia Antipolis Nice, Nice, France 3 ...
gut.bmj3d
Epidemiology of gastro-oesophageal reflux disease: a systematic review
Correspondence to: Professor J Dent Department of Gastroenterology, Hepatology, and General Medicine, Level 7, North Wing, North Terrace, Royal Adelaide Hospital, Adelaide, South Australia 5000, ...